UBS has maintained a 'Buy' rating for AKESO despite lowering its revenue forecasts for 2026 and 2027 due to disappointing revenue growth and an expanded net loss in the second half of last year. The target price has been reduced from HKD196.5 to HKD173.4, reflecting adjustments in sales and R&D expense forecasts.
